首页> 中文期刊> 《海南医学 》 >利用慢病毒载体构建稳定干扰AMPKα1的HeLa细胞系

利用慢病毒载体构建稳定干扰AMPKα1的HeLa细胞系

             

摘要

目的 建立稳定干扰AMPKα1的HeLa细胞系.方法 利用AMPKα1慢病毒干扰质粒PLKO.1-puro-AMPKα1转染293T细胞制备重组慢病毒,然后用重组慢病毒感染HeLa细胞,荧光显微镜观察病毒感染效率,免疫印迹实验检测Sh-AMPKα1病毒感染组的AMPKα1表达.然后采用嘌呤霉素筛选出稳定干扰AMPKα1的HeLa细胞单克隆,免疫印迹实验和免疫荧光实验检测AMPKα1表达情况.最后用AMPK激活剂Metformin实验验证AMPKα1稳定干扰的Hela细胞中AMPKα1蛋白的表达以及AMPKα1的生物功能.结果 荧光拍照结果显示慢病毒成功感染Hela细胞;免疫印迹实验显示特异性Sh-AMPKα1病毒感染组的AMPKα1表达[(0.58±0.02)DPI]比WT组[(1.00±0.00)DPI]低,免疫荧光实验结果也显示Sh-AMPKα1病毒感染组中AMPKα1的平均光密度[(0.09±0.01)IOD/area]比WT组[(1.00±0.00)IOD/area]要低,差异均具有显著统计学意义(P<0.01);经AMPK激活剂Metformin处理后,AMPKα1稳定干扰的Hela细胞中仍无AMPKα1蛋白表达,并且Sh-AMPKα1组中LC3-Ⅱ/Ⅰ/Actin[(1.00±0.00I)DPI]也显著低于HA-AMPKα1组[(1.62±0.02)DPI],表明病毒感染组细胞中AMPKα1不能发挥其生物功能,差异具有显著统计学意义(P<0.01).结论 利用ShRNA-AMPKα1慢病毒筛选出了高效干扰AMPKα1表达的HeLa细胞系,为后续深入研究AMPKα1的生物功能奠定了基础.%Objective To establish adenosine monophosphate-activated protein kinaseα1 (AMPKα1) stably in-terfered Hela cell line. Methods Lentiviral vector PLKO.1-puro-AMPKα1 was transfected into 293T cells to prepare recombinant lentivirus. Then HeLa cells were infected with the recombinant lentivirus, and the efficiency of virus infec-tion was detected by fluorescent photography. The monoclonal Hela cell stably interfered AMPKα1 was screened by pu-romycin, and Western blot and immunofluorescence were used to detecte the expression of AMPKα1 in specific Sh-AMPKα1 virus infected group. Finally, the biological function of AMPKα1 in Hela cells stably interfered with AMPKα1 under the treatment of metformin, a AMPK activator, was detected. Results The results of fluorescent pho-tography showed that the virus infection was highly efficient. Immunoblotting results showed that the expression of AMPKα1 was significantly reduced in Hela cells stably interfered with AMPKα1 (0.58 ± 0.02) DPI compared with the WT group (1.00 ± 0.00) DPI. Immunofluorescence results also showed that the mean optical density of AMPKα1 was (0.09±0.01) IOD/area in Sh-AMPKα1 virus infected group versus (1.00±0.00) IOD/area in the WT group. All the above differences were statistically significant (P<0.01). After the treatment of metformin, the expression of AMPKα1 in the Sh-AMPKα1 virus infected group was still not expressed. Moreover, the relative ratio of LC3-Ⅱ/Ⅰ/Actinin in the Sh-AMPKα1 group was (1.00 ± 0.00) DPI, which was significantly lower than (1.62 ± 0.02) DPI in the HA-AMPKα1 group, indicating that AMPKα1 could not play its biological function (P<0.01). Conclusion The above results revealed that AMPKα1 effectively interfered Hela cell line was established by ShRNA-AMPKα1 lentivirus, which laid the foun-dation for the further research of AMPKα1 biological function.

著录项

  • 来源
    《海南医学 》 |2017年第23期|3785-3789|共5页
  • 作者单位

    广东医科大学,广东 湛江 524001;

    广东医科大学,广东 湛江 524001;

    广东医科大学,广东 湛江 524001;

    广东医科大学,广东 湛江 524001;

    广东医科大学附属医院神经病学研究所广东省衰老相关心脑疾病重点实验室,广东 湛江 524001;

    广东医科大学附属医院神经内科,广东 湛江 524001;

    广东医科大学附属医院神经病学研究所广东省衰老相关心脑疾病重点实验室,广东 湛江 524001;

    广东医科大学附属医院神经病学研究所广东省衰老相关心脑疾病重点实验室,广东 湛江 524001;

  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 人体病毒学(致病病毒) ;
  • 关键词

    慢病毒载体 ; AMPKα1; RNA干扰 ; Hela细胞 ; Metformin;

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号